What ETF is like ARKK?
| Ticker | Name | YTD% |
|---|---|---|
| ARKK | ARK Innovation ETF | -- |
| BTEK | BlackRock Future Tech ETF | -- |
| GTEK | Goldman Sachs Future Tech Leaders Equity ETF | -- |
| LOUP | Innovator Loup Frontier Tech ETF | -- |
ARKK has fallen more than 50% in 2022 alone. On Friday it dropped as much as 7.5% on the latest inflation figures. What's more, every fund in Wood's lineup — which track tech themes like robotics and fintech — has tumbled more than 20% this year, and the smaller offerings haven't benefited from inflows.
The primary difference between ARKK and VGT is the company that offers the exchange-traded fund (ETF). ARKK is offered by ARK Invest. VGT is offered by Vanguard.
That underperformance continued into 2022 with the ARKK ETF down more than 56% through May 9 compared to the Nasdaq's 25.7% fall through the same period. With the ARKK ETF about 70% off its 52-week high, the ETF is not a buy right now.
ARKK's total expense ratio works out to 0.75% as opposed to ARKW's figure of 0.83%; ARKW's number is higher because, in addition to the standard 0.75% management fee that both ETFs incur, ARKW also faces additional expenses to the tune of 0.08% that arise due to its investment in other ETFs and money market funds.
Consolidations are often followed by break-outs, so ARKK's upside looks promising. Buying ARKK while its share price has taken a hit offers significant upside potential for long-term holders. However, the volatility of the underlying holdings means significant turbulence could be experience in the short to medium term.
There Was No Pandemic Case: ARKK just continues on its 33% CAGR path as it was before the pandemic. Normal Conservative Case: Today's profitable companies return to fair value and grow at the rate of projected earnings growth while unprofitable companies merely return to fair value.
The ETF shorting Cathie Wood's ARK Innovation Fund (ARKK) has been a big winner in 2022. The Tuttle Capital Short Innovation ETF (SARK) has soared more than 75% year-to-date while the ARKK ETF has fallen more than 55% in the same time period.
ARKK's Undervalued Stocks
A “value” stock can be overvalued or undervalued. Currently, all of ARKK's holdings--with the exceptions of Tesla, Exact Sciences, and Block (SQ)--are trading below Morningstar's fair value estimate.
It's also managed by the famous Catherine Wood, so is ARKG a good ETF to buy? The fund has a heavy exposure to biotechnology – a good spot during a pandemic. In fact, it started 2021 with over 96.6 percent of its holdings in healthcare. It also holds minimal positions in technology and consumer defensive stocks.
Why is ARKK down?
Ark Innovation ETF (NYSEARCA:ARKK) has fallen hard since the beginning of 2022 because its investors have continued to come to their senses. Unfortunately, it is too late for many of them.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circ*mstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation.
ARK Innovation's (ARKK) concept isn't backed up by credible ETF research, and that's why it has capitulated under changing market circ*mstances. The fund's information ratio suggests that it's not managed efficiently.
Renowned investor Cathie Wood's flagship Ark Innovation ETF (ARKK) - Get ARK Innovation ETF Report is on the rebound. It has bounced back 24% from its May 12 intraday low. The fund remains off 54% year to date and off 73% from its February 2021 high.
ARK ETF Overview
With 8 ETFs traded on the U.S. markets, ARK ETFs have total assets under management of $16.68B.
| Symbol | ETF Name | Annual Dividend Yield % |
|---|---|---|
| ARKK | ARK Innovation ETF | 1.74% |
| ARKG | ARK Genomic Revolution ETF | 1.07% |
| ARKW | ARK Next Generation Internet ETF | 1.23% |
| ARKQ | ARK Autonomous Technology & Robotics ETF | 0.75% |
ARK Innovation ETF (ARKK)
ARKK has a dividend yield of 0.51% and paid $0.26 per share in the past year. The dividend is paid once per year and the last ex-dividend date was Dec 29, 2021.
The results aren't too big of a surprise given ARK Innovation (ARKK) is the flagship and best-known fund and enjoyed a strong five-year return. ARK Genomic (ARKG) and ARK Fintech (ARKF) finished in second and third place, respectively.
...
Zacks Premium Research for ARKK.
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
Her estimated net worth of $140 million is sharply down from $400 million last year and falls well short of the $215 million cutoff to make this year's top 100. Forbes estimates that her majority ownership stake in her firm is worth about $125 million.
Is ARKK leveraged?
Currently, ARK's ETFs do not use any leverage.
The ETF shorting Cathie Wood's ARK Innovation Fund (ARKK) has been a big winner in 2022. The Tuttle Capital Short Innovation ETF (SARK) has soared more than 75% year-to-date while the ARKK ETF has fallen more than 55% in the same time period.
| Symbol | ETF Name | Annual Dividend Yield % |
|---|---|---|
| ARKK | ARK Innovation ETF | 1.74% |
| ARKG | ARK Genomic Revolution ETF | 1.07% |
| ARKW | ARK Next Generation Internet ETF | 1.23% |
| ARKQ | ARK Autonomous Technology & Robotics ETF | 0.75% |
ARK Innovation ETF (NYSEARCA:ARKK) is becoming undervalued, secondary to the classic overcorrection phenomenon that occurs to an equity based security, after a period of overvaluation.
ARKK's Undervalued Stocks
A “value” stock can be overvalued or undervalued. Currently, all of ARKK's holdings--with the exceptions of Tesla, Exact Sciences, and Block (SQ)--are trading below Morningstar's fair value estimate. The top seven holdings all trade between 3- and 5-star levels.
